A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00556322 · COMPLETED
Trial details
- NCT number
- NCT00556322
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2012-06-01
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.